Zoetis (ZTS) Research & Development (2012 - 2026)
Zoetis (ZTS) reported Research & Development of $80 million for Q1 2015, down 8.0% from $87 million a year earlier and down 35.5% from the prior quarter.
Powered by 
Analysis
Zoetis (ZTS) Research & Development (2012 - 2026) Analysis & Trends
Over the twelve months ended Mar 29, 2015, Zoetis' Research & Development came in at $389 million, down 1.8% year-over-year; for FY2014, it came in at $396 million, down 0.8% from FY2013.
- Research & Development has declined for three consecutive years, with a three-year compound annual growth rate of -2.5% (FY2011 to FY2014).
- By year, Research & Development came in at $399 million in FY2013 (-2.4%), $409 million in FY2012 (-4.2%) and $427 million in FY2011.
- The Q1 2015 figure ranks as the lowest quarterly Research & Development in data going back to Q1 2012.
- Year over year, Research & Development gained in two of the last eight quarters, with an average decline of 1.2%.
- The high point for year-over-year Research & Development in five years was Q2 2013 (growth of 3.3%); the low point was Q1 2013 (a decline of 11.8%).
- Per Business Quant data, the three quarters before Q1 2015 came in at $124 million (Q4 2014), $93 million (Q3 2014) and $92 million (Q2 2014).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Zoetis | 33.38 Bn | 25.23 Bn | 1.80 Bn | 173.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 173.00 Mn |
| Mar 31, 2026 | 180.00 Mn |
| Dec 31, 2025 | 199.00 Mn |
| Sep 30, 2025 | 170.00 Mn |
| Jun 30, 2025 | 166.00 Mn |
| Mar 31, 2025 | 162.00 Mn |
| Dec 31, 2024 | 186.00 Mn |
| Sep 30, 2024 | 167.00 Mn |
| Jun 30, 2024 | 171.00 Mn |
| Mar 31, 2024 | 162.00 Mn |
| Dec 31, 2023 | 174.00 Mn |
| Sep 30, 2023 | 152.00 Mn |
| Jun 30, 2023 | 146.00 Mn |
| Mar 31, 2023 | 142.00 Mn |
| Dec 31, 2022 | 148.00 Mn |
| Sep 30, 2022 | 134.00 Mn |
| Jun 30, 2022 | 135.00 Mn |
| Mar 31, 2022 | 122.00 Mn |
| Dec 31, 2021 | 138.00 Mn |
| Sep 30, 2021 | 132.00 Mn |
API Access
Zoetis Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=ZTS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "ZTS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=ZTS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();